Pileflebitis idiopática en paciente con mutación del factor V Leiden
نویسندگان
چکیده
منابع مشابه
Paniculitis en paciente con dermatomiositis
Panniculitis is a rarely reported clinical finding in dermatomyositis. It may precede the other manifestations associated with dermatomyositis by as much as 14 months. In all cases, myositis and panniculitis improve simultaneously during treatment. The present report describes the case of a 30-year-old female patient with clinical and histopathological findings consistent with panniculitis two ...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملSulfonilureas en el tratamiento del paciente con diabetes mellitus tipo 2
Sulfonylureas are insulin-secreting drugs that act on specific pancreatic beta-cell receptors. Although initial monotherapy of type 2 diabetes mellitus should focus on the use of metformin, sulfonylureas continue to be effective in the treatment of this disease, provided they are used early when there is still some beta-cell function and, especially, in combination with other oral drugs (metfor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anales de Medicina Interna
سال: 2006
ISSN: 0212-7199
DOI: 10.4321/s0212-71992006000700015